sakine akar

Dr. sakine akar


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2022 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
SAsakine akar
sakine akar
HDHamiyet Donmez-Altuntas
Hamiyet Donmez-Altuntas
ZHZuhal Hamurcu
Zuhal Hamurcu

1 October 2021 in Turkish Journal of Emergency Medicine
Verified
Journal Article
Open access
PDF file
MCMurat Cetin
Murat Cetin
BKBora Kaya
Bora Kaya
TKTurgay Yilmaz Kilic
Turgay Yilmaz Kilic
NHNazife Didem Hanoğlu
Nazife Didem Hanoğlu
ŞGŞervan Gökhan
Şervan Gökhan
SYSerkan Yilmaz
Serkan Yilmaz
OBJECTIVES: This study aimed to evaluate pain management practices in the emergency departments (EDs) in Turkey and to evaluate the prevalence and etiologies of oligoanalgesia to identify possible improvement strategies. METHODS: This multicenter cross-sectional observational study was conducted in 10 tertiary care hospitals in Turkey. Patients who were admitted to the ED with pain chief complaints were included in the study. Both patients and physicians were surveyed with two separate forms by the research associates, respectively. The patient survey collected data about the pain and the interventions from the patients' perspective. The pain was evaluated using the Numerical Rating Scale. The physician survey collected data to assess the differences between study centers on pain management strategies and physician attitudes in pain management. RESULTS: Ten emergency physicians and 740 patients (male/female: 365/375) enrolled in the study. The median pain score at admission at both triage and ED was 7 (interquartile range: 5–8). The most frequent type of pain at admission was headache (n = 184, 24.7%). The most common analgesics ordered by physicians were nonsteroidal anti-inflammatory drugs (n = 505, 67.9%), and the most frequent route of administration was intramuscular injection (n = 396, 53.2%). About half of the patients (n = 366, 49.2%) received analgesics 10–30 min from ED admission. The posttreatment median pain score decreased to 3 (P < 0.001). About 79.2% of patients did not need a second analgesic administration (n = 589), and opioid analgesics were the most frequently administered analgesic if the second application was required. Physicians prescribed an analgesic at discharge from the ED in 55.6% of the patients (n = 414) and acute pain was present in 7.5% (n = 56) of the patients. CONCLUSION: Our study on the pain management practices in the EDs in Turkey suggested that high rate of intramuscular analgesic use and long emergency room stay durations are issues that should constitute the focus of our quality improvement efforts in pain management.

3 January 2024 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
SAsakine akar
sakine akar
MCMustafa Cakir
Mustafa Cakir
HOHalil Ozkol
Halil Ozkol
SASenem Akkoc
Senem Akkoc
BOBerna Ozdem
Berna Ozdem

9 September 2024 in Photochemical & Photobiological Sciences
Verified
Journal Article
Closed access
PDF file
GEGulsah Evyapan
Gulsah Evyapan
HOHalil Ozkol
Halil Ozkol
HOHatice Uce Ozkol
Hatice Uce Ozkol
ÖAÖzge Alvur
Özge Alvur
SAsakine akar
sakine akar

13 May 2026 in Journal of Biochemical and Molecular Toxicology
Verified
Journal Article
Open access
PDF file
SAsakine akar
sakine akar
OAOzge Alvur
Ozge Alvur
GEGulsah Evyapan
Gulsah Evyapan
BOBerna Ozdem
Berna Ozdem
IDIlknur Porsuk Doru
Ilknur Porsuk Doru
The pathogenesis of Alzheimer's disease (AD) involves amyloid beta (Aβ)‐induced oxidative stress, apoptotic cell death, and neuroinflammation, contributing to neuronal dysfunction. In our study, a differentiation protocol using retinoic acid was applied to SH‐SY5Y cells to generate a neuron‐like phenotype, and the neuroprotective efficacy of Escin was investigated by inducing Aβ1‐42‐mediated cytotoxicity. The experimental protocol involved an initial treatment with 2 µM Escin prior to Aβ1‐42 application. Cell viability, intracellular reactive oxygen species (ROS), apoptosis, and inflammatory mediator expression (NF‐κB, TNF‐α, IL‐1β) were assessed by MTT assay, flow cytometry with DCFH‐DA, flow cytometry with Annexin V‐FITC/7‐AAD staining, and RT‐qPCR, respectively. In our results, Aβ1‐42 exposure was found to significantly reduce cell viability and increase ROS production. Additionally, it was observed to enhance apoptotic cell death and increase pro‐inflammatory gene expression. Escin pretreatment was found to significantly mitigate these effects by reducing oxidative stress, apoptosis, and NF‐κB‐mediated inflammatory signaling. Furthermore, galantamine (10 µM), an approved AD treatment agent, was used as a positive control to compare the effects of Escin and confirmed the experimental model by exhibiting protective effects. In conclusion, these findings demonstrate that Escin is a promising neuroprotective agent and warrant further investigation into its potential to mitigate Aβ‐related neuronal damage in AD.

1 January 2022 in Turkish Journal of Trauma and Emergency Surgery
Verified
Journal Article
Open access
SAsakine akar
sakine akar
ZHZuhal Hamurcu
Zuhal Hamurcu